REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,799.50
Bid: 1,796.00
Ask: 1,796.50
Change: 19.00 (1.07%)
Spread: 0.50 (0.028%)
Open: 1,784.00
High: 1,799.50
Low: 1,780.00
Prev. Close: 1,780.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

28 Nov 2018 08:35

Unilever close to buying GSK's Horlicks business - report

(Sharecast News) - Unilever is in pole position to guzzle up GlaxoSmithKline's Indian Horlicks business and associated nutrition brands for around $4bn, according to reports.

Read more
23 Nov 2018 11:19

Manchester & London Investment Trust Ahead Of Benchmark In Full Year

LONDON (Alliance News) - Manchester & London Investment Trust PLC on Friday upped its dividend by a third as it outperformed its benchmark in its recently ended financial year.In &

Read more
22 Nov 2018 08:33

TOP NEWS: GSK Signs Anaemia Drug Distribution Deal With Japanese Firm

LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday it has signed a strategic commercialisation deal for its anaemia drug Daprodustat with Japanese firm Hakko Kirin Co Ltd.Financial

Read more
31 Oct 2018 15:42

EXTRA: Glaxo Tightens Outlook To Upper End Of Estimates On Shingrix

LONDON (Alliance News) - GlaxoSmithKline PLC on Wednesday posted a flat third quarter pretax profit and tightened annual outlook to upper end of its estimates due to higher than expected sales of

Read more
31 Oct 2018 12:42

TOP NEWS: Glaxo Tightens Annual Outlook To Upper End Of Estimates

LONDON (Alliance News) - GlaxoSmithKline PLC on Wednesday posted a flat third quarter profit and tightened annual outlook to upper end of its estimates on continuation of strong trading in Glaxo a

Read more
31 Oct 2018 12:27

GSK tightens guidance as new shingles drug boosts earnings

(Sharecast News) - GlaxoSmithKline tightened up its full year guidance after a strong launch for its new Shingrix shingles vaccine helped the drug maker to a stronger than expected third quarter.

Read more
30 Oct 2018 16:23

Wednesday preview: BoJ, GlaxoSmithKline and Next in the spotlight

(Sharecast News) - Barring surprises, the focus on Wednesday will likely be on the Bank of Japan's monetary policy meeting, with traders scanning the headlines for any whiff of any potential near-term shifts in its policy settings.

Read more
30 Oct 2018 15:02

Glaxo Reports Positive Data For ViiV Healthcare's FLAIR HIV Study

LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that ViiV Healthcare's FLAIR study met its primary endpoint, reporting "positive headline results".ViiV is a HIV by -

Read more
29 Oct 2018 10:51

GlaxoSmithKline reports encouraging results from HIV drug trial

(Sharecast News) - Blue chip GlaxoSmithKline said a study into a new HIV drug regime, which could dramatically reduce the number of annual doses required, had been "encouraging".

Read more
29 Oct 2018 10:39

GSK Finds Anaemia Treatment Option, ViiV Presents 3-Year Research Data

LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said the results from a phase 3 study of daprodustat in Japanese patients with anaemia showed positive results.The pharmaceutical said

Read more
24 Oct 2018 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 25 October Lloyds Banking GroupQ3 ResultsRELXQ3 ResultsAir 26

Read more
22 Oct 2018 07:26

TOP NEWS: GSK Reports Encouraging Results From Arthritis Drug Trial

LONDON (Alliance News) - GlaxoSmithKline PLC on Sunday said a phase two study of its rheumatoid arthritis drug showed promising results.The drug, GSK3196165, is also known as GSK165 and was

Read more
18 Oct 2018 16:47

GlaxoSmithKline's ViiV Healthcare Submits New HIV Drug Application

LONDON (Alliance News) - GlaxoSmithKline PLC on Thursday said ViiV Healthcare has submitted a new drug application to the US Food & Drug Administration.The submission covers a two-drug

Read more
8 Oct 2018 13:07

Monday broker round-up

(Sharecast News) - Mediclinic International: Investec upgrades to buy with a target price of 448p.

Read more
25 Sep 2018 18:42

GSK Vaccine Significantly Reduces Tuberculosis In Infected Patients

LONDON (Alliance News) - GlaxoSmithKline PLC on Tuesday said it candidate vaccine, M72/AS01E, was shown to significantly reduce pulmonary tuberculosis in adults with latent tuberculosis results of

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.